Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?What condition primarily benefits from sapropterin therapy?Lipitor vs generics what's the price gap?Is januvia still on the market?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for bosentan
Bosentan, sold as Tracleer, causes serious birth defects and fetal harm. It is pregnancy category X, meaning the risks outweigh any benefits, and it should not be used by pregnant women or those planning pregnancy.[1][2]
Semen contains bosentan, which may harm a fetus if a partner becomes pregnant. Men must use condoms with female partners of childbearing potential during treatment and for 3 months after the last dose.[1]
Stop bosentan right away. Enroll in the Tracleer Pregnancy Surveillance Program to report outcomes. Fetal risks include teratogenic effects like skull and limb defects, based on animal studies and human case reports.[1][2]
Bosentan induces CYP3A4, reducing effectiveness of hormonal contraceptives like pills, patches, or rings. Do not rely on them alone; always combine with a barrier method.[1] Sources [1]: Tracleer Prescribing Information (FDA) [2]: REMS@FDA - Tracleer
Other Questions About Bosentan :